![Veritas In Silico logo](/img/home/hero/veritas-in-silico.png)
Veritas In Silico Inc.
IPO
Feb 8, 2024
TSE Growth Market
Veritas In Silico has developed their ibVIS platform that combines informatics and experimental biology and has been conducting research for discovering mRNA-targeted small molecule drugs in collaboration with many pharmaceutical companies.
Global Brain is hopeful that Veritas In Silico will continue to make even greater strides as a pioneer paving the way for new areas in the pharmaceutical industry.
Veritas In Silico Inc.
IPO
Feb 8, 2024
TSE Growth Market
$1.9B
under management
350+
active portfolio
34
IPOs
69
M&As
Global Brain is an independent venture capital firm that aims to bring new industries to the society through extensive hands-on support for startups and open innovation with large corporations.
Our Funds & Projects
A rare fund operation in the world that helps collaborations between startups and enterprise companies.
Our Team
68
InvestmentMembers
29
SupportMembers
14
Fund ManagementMembers
29
OperationMembers
Inquiries from entrepreneurs are greatly appreciated. Please feel free to contact us even if you are in the process of preparing a project or if your idea has not yet taken shape.